aluates Reports

$ 0.0

Automative

Global Fatty Acid Synthase (FASN) Inhibitors Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-26X5219

Global Fatty Acid Synthase FASN Inhibitors Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Fatty Acid Synthase (FASN) Inhibitors Market Research Report 2025

Code: QYRE-Auto-26X5219

Report

June 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Abcam

Tocris Bioscience

MedChemexpress LLC

Sagimet Biosciences

R&D Systems

Santa Cruz Biotechnology

Fatty Acid Synthase (FASN) Inhibitors Market

The global market for Fatty Acid Synthase (FASN) Inhibitors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Fatty Acid Synthase (FASN) Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide. FASN is a key enzyme involved in the production of saturated fatty acids in the liver and other organs and is the only enzyme in the human body capable of converting metabolized sugars into palmitate. Palmitate is a saturated fatty acid that serves as a building block for longer chain, polyunsaturated fatty acids and can directly interact with other proteins to sustain normal cell signaling and metabolic function. The overproduction of palmitate is a critical driver of cellular metabolic dysfunction that can drive development or progression of several different diseases. In patients with NASH, increased FASN-mediated palmitate synthesis in the liver is the source of three key drivers of the disease: excess accumulation of liver fat, inflammation and fibrosis. If left untreated, these can lead to cirrhosis of the liver, liver cancer and/or liver transplantation.

North American market for Fatty Acid Synthase (FASN) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Fatty Acid Synthase (FASN) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Fatty Acid Synthase (FASN) Inhibitors in Medical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Fatty Acid Synthase (FASN) Inhibitors include Merck, Abcam, Tocris Bioscience, MedChemExpress, Sagimet Biosciences, R＆D Systems, Santa Cruz Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Fatty Acid Synthase (FASN) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Acid Synthase (FASN) Inhibitors.

The Fatty Acid Synthase (FASN) Inhibitors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fatty Acid Synthase (FASN) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fatty Acid Synthase (FASN) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Fatty Acid Synthase (FASN) Inhibitors Market Report

Report Metric	Details
Report Name	Fatty Acid Synthase (FASN) Inhibitors Market
Segment by Type	Powder Solid
Segment by Application	Medical Research Laboratories Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Abcam, Tocris Bioscience, MedChemExpress, Sagimet Biosciences, R＆D Systems, Santa Cruz Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Acid Synthase (FASN) Inhibitors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fatty Acid Synthase (FASN) Inhibitors Market report?

Ans: The main players in the Fatty Acid Synthase (FASN) Inhibitors Market are Merck, Abcam, Tocris Bioscience, MedChemExpress, Sagimet Biosciences, R＆D Systems, Santa Cruz Biotechnology

What are the Application segmentation covered in the Fatty Acid Synthase (FASN) Inhibitors Market report?

Ans: The Applications covered in the Fatty Acid Synthase (FASN) Inhibitors Market report are Medical, Research Laboratories, Other

What are the Type segmentation covered in the Fatty Acid Synthase (FASN) Inhibitors Market report?

Ans: The Types covered in the Fatty Acid Synthase (FASN) Inhibitors Market report are Powder, Solid

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Powder

1.2.3 Solid

1.3 Market by Application

1.3.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Medical

1.3.3 Research Laboratories

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Perspective (2020-2031)

2.2 Global Fatty Acid Synthase (FASN) Inhibitors Growth Trends by Region

2.2.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Fatty Acid Synthase (FASN) Inhibitors Historic Market Size by Region (2020-2025)

2.2.3 Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Region (2026-2031)

2.3 Fatty Acid Synthase (FASN) Inhibitors Market Dynamics

2.3.1 Fatty Acid Synthase (FASN) Inhibitors Industry Trends

2.3.2 Fatty Acid Synthase (FASN) Inhibitors Market Drivers

2.3.3 Fatty Acid Synthase (FASN) Inhibitors Market Challenges

2.3.4 Fatty Acid Synthase (FASN) Inhibitors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Fatty Acid Synthase (FASN) Inhibitors Players by Revenue

3.1.1 Global Top Fatty Acid Synthase (FASN) Inhibitors Players by Revenue (2020-2025)

3.1.2 Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Players (2020-2025)

3.2 Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Fatty Acid Synthase (FASN) Inhibitors Revenue

3.4 Global Fatty Acid Synthase (FASN) Inhibitors Market Concentration Ratio

3.4.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fatty Acid Synthase (FASN) Inhibitors Revenue in 2024

3.5 Global Key Players of Fatty Acid Synthase (FASN) Inhibitors Head office and Area Served

3.6 Global Key Players of Fatty Acid Synthase (FASN) Inhibitors, Product and Application

3.7 Global Key Players of Fatty Acid Synthase (FASN) Inhibitors, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Fatty Acid Synthase (FASN) Inhibitors Breakdown Data by Type

4.1 Global Fatty Acid Synthase (FASN) Inhibitors Historic Market Size by Type (2020-2025)

4.2 Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Type (2026-2031)

5 Fatty Acid Synthase (FASN) Inhibitors Breakdown Data by Application

5.1 Global Fatty Acid Synthase (FASN) Inhibitors Historic Market Size by Application (2020-2025)

5.2 Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Fatty Acid Synthase (FASN) Inhibitors Market Size (2020-2031)

6.2 North America Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2020-2025)

6.4 North America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Fatty Acid Synthase (FASN) Inhibitors Market Size (2020-2031)

7.2 Europe Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2020-2025)

7.4 Europe Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size (2020-2031)

8.2 Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2020-2025)

8.4 Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size (2020-2031)

9.2 Latin America Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2020-2025)

9.4 Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size (2020-2031)

10.2 Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2020-2025)

10.4 Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Fatty Acid Synthase (FASN) Inhibitors Introduction

11.1.4 Merck Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Abcam

11.2.1 Abcam Company Details

11.2.2 Abcam Business Overview

11.2.3 Abcam Fatty Acid Synthase (FASN) Inhibitors Introduction

11.2.4 Abcam Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

11.2.5 Abcam Recent Development

11.3 Tocris Bioscience

11.3.1 Tocris Bioscience Company Details

11.3.2 Tocris Bioscience Business Overview

11.3.3 Tocris Bioscience Fatty Acid Synthase (FASN) Inhibitors Introduction

11.3.4 Tocris Bioscience Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

11.3.5 Tocris Bioscience Recent Development

11.4 MedChemExpress

11.4.1 MedChemExpress Company Details

11.4.2 MedChemExpress Business Overview

11.4.3 MedChemExpress Fatty Acid Synthase (FASN) Inhibitors Introduction

11.4.4 MedChemExpress Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

11.4.5 MedChemExpress Recent Development

11.5 Sagimet Biosciences

11.5.1 Sagimet Biosciences Company Details

11.5.2 Sagimet Biosciences Business Overview

11.5.3 Sagimet Biosciences Fatty Acid Synthase (FASN) Inhibitors Introduction

11.5.4 Sagimet Biosciences Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

11.5.5 Sagimet Biosciences Recent Development

11.6 R＆D Systems

11.6.1 R＆D Systems Company Details

11.6.2 R＆D Systems Business Overview

11.6.3 R＆D Systems Fatty Acid Synthase (FASN) Inhibitors Introduction

11.6.4 R＆D Systems Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

11.6.5 R＆D Systems Recent Development

11.7 Santa Cruz Biotechnology

11.7.1 Santa Cruz Biotechnology Company Details

11.7.2 Santa Cruz Biotechnology Business Overview

11.7.3 Santa Cruz Biotechnology Fatty Acid Synthase (FASN) Inhibitors Introduction

11.7.4 Santa Cruz Biotechnology Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

11.7.5 Santa Cruz Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Abcam

Tocris Bioscience

MedChemexpress LLC

Sagimet Biosciences

R&D Systems

Santa Cruz Biotechnology

List of Tables

Table 1. Global Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Powder

Table 3. Key Players of Solid

Table 4. Global Fatty Acid Synthase (FASN) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Region (2020-2025)

Table 8. Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Region (2026-2031)

Table 10. Fatty Acid Synthase (FASN) Inhibitors Market Trends

Table 11. Fatty Acid Synthase (FASN) Inhibitors Market Drivers

Table 12. Fatty Acid Synthase (FASN) Inhibitors Market Challenges

Table 13. Fatty Acid Synthase (FASN) Inhibitors Market Restraints

Table 14. Global Fatty Acid Synthase (FASN) Inhibitors Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Players (2020-2025)

Table 16. Global Top Fatty Acid Synthase (FASN) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Acid Synthase (FASN) Inhibitors as of 2024)

Table 17. Ranking of Global Top Fatty Acid Synthase (FASN) Inhibitors Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Fatty Acid Synthase (FASN) Inhibitors Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Fatty Acid Synthase (FASN) Inhibitors, Headquarters and Area Served

Table 20. Global Key Players of Fatty Acid Synthase (FASN) Inhibitors, Product and Application

Table 21. Global Key Players of Fatty Acid Synthase (FASN) Inhibitors, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Type (2020-2025)

Table 25. Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Type (2026-2031)

Table 27. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Application (2020-2025)

Table 29. Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Application (2026-2031)

Table 31. North America Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 46. Merck Company Details

Table 47. Merck Business Overview

Table 48. Merck Fatty Acid Synthase (FASN) Inhibitors Product

Table 49. Merck Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025) & (US$ Million)

Table 50. Merck Recent Development

Table 51. Abcam Company Details

Table 52. Abcam Business Overview

Table 53. Abcam Fatty Acid Synthase (FASN) Inhibitors Product

Table 54. Abcam Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025) & (US$ Million)

Table 55. Abcam Recent Development

Table 56. Tocris Bioscience Company Details

Table 57. Tocris Bioscience Business Overview

Table 58. Tocris Bioscience Fatty Acid Synthase (FASN) Inhibitors Product

Table 59. Tocris Bioscience Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025) & (US$ Million)

Table 60. Tocris Bioscience Recent Development

Table 61. MedChemExpress Company Details

Table 62. MedChemExpress Business Overview

Table 63. MedChemExpress Fatty Acid Synthase (FASN) Inhibitors Product

Table 64. MedChemExpress Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025) & (US$ Million)

Table 65. MedChemExpress Recent Development

Table 66. Sagimet Biosciences Company Details

Table 67. Sagimet Biosciences Business Overview

Table 68. Sagimet Biosciences Fatty Acid Synthase (FASN) Inhibitors Product

Table 69. Sagimet Biosciences Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025) & (US$ Million)

Table 70. Sagimet Biosciences Recent Development

Table 71. R＆D Systems Company Details

Table 72. R＆D Systems Business Overview

Table 73. R＆D Systems Fatty Acid Synthase (FASN) Inhibitors Product

Table 74. R＆D Systems Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025) & (US$ Million)

Table 75. R＆D Systems Recent Development

Table 76. Santa Cruz Biotechnology Company Details

Table 77. Santa Cruz Biotechnology Business Overview

Table 78. Santa Cruz Biotechnology Fatty Acid Synthase (FASN) Inhibitors Product

Table 79. Santa Cruz Biotechnology Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025) & (US$ Million)

Table 80. Santa Cruz Biotechnology Recent Development

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

Table 84. Authors List of This Report

List of Figures

Figure 1. Fatty Acid Synthase (FASN) Inhibitors Picture

Figure 2. Global Fatty Acid Synthase (FASN) Inhibitors Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Type: 2024 VS 2031

Figure 4. Powder Features

Figure 5. Solid Features

Figure 6. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Application: 2024 VS 2031

Figure 8. Medical Case Studies

Figure 9. Research Laboratories Case Studies

Figure 10. Other Case Studies

Figure 11. Fatty Acid Synthase (FASN) Inhibitors Report Years Considered

Figure 12. Global Fatty Acid Synthase (FASN) Inhibitors Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Fatty Acid Synthase (FASN) Inhibitors Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Region: 2024 VS 2031

Figure 15. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Players in 2024

Figure 16. Global Top Fatty Acid Synthase (FASN) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Acid Synthase (FASN) Inhibitors as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Fatty Acid Synthase (FASN) Inhibitors Revenue in 2024

Figure 18. North America Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Fatty Acid Synthase (FASN) Inhibitors Market Share by Country (2020-2031)

Figure 20. United States Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Fatty Acid Synthase (FASN) Inhibitors Market Share by Country (2020-2031)

Figure 24. Germany Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Share by Region (2020-2031)

Figure 32. China Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Share by Country (2020-2031)

Figure 40. Mexico Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Share by Country (2020-2031)

Figure 44. Turkey Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Merck Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

Figure 48. Abcam Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

Figure 49. Tocris Bioscience Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

Figure 50. MedChemExpress Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

Figure 51. Sagimet Biosciences Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

Figure 52. R＆D Systems Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

Figure 53. Santa Cruz Biotechnology Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Fatty Acids Supplement Market Research Report 2024

Non Alcoholic Steatohepatitis NASH Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global NASH Non alcoholic Steatohepatitis Biomarkers Market Research Report 2024

Global Non Alcoholic Fatty Liver Disease Treatment Market Research Report 2024

Non Alcoholic Steatohepatitis Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nonalcoholic Steatohepatitis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nonalcoholic Steatohepatitis NASH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2025

Global Heart shaped Fatty Acid Binding Protein Detection Kit Market Research Report 2024

Non alcoholic Steatohepatitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti SCD1 Antibody Market Research Report 2024

Global Fatty Acid Binding Protein 1 FABP1 ELISA Kit Market Research Report 2024

Fatty Liver Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nonalcoholic Steatohepatitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Liver Models Market Research Report 2024

Drugs for Fatty Acid Oxidation Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Citrate Synthetase Antibody Market Research Report 2024

Global Fatty Acyl CoA Assay Kit Market Research Report 2025

Global Long acting Polypeptide Fatty Acid Side Chain Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions